Skip Navigation LinksHome > April 15, 2000 - Volume 23 - Issue 5 > Distribution of HIV-1 Subtypes Among HIV-Seropositive Patien...
JAIDS Journal of Acquired Immune Deficiency Syndromes:
Article: PDF Only

Distribution of HIV-1 Subtypes Among HIV-Seropositive Patients in the Interior of Cote d'Ivoire.

Nkengasong, John N.; Luo, Chi-Cheng; Abouya, Lucien; Pieniazek, Danuta; Maurice, Chantal; Sassan-Morokro, Madeleine; Ellenberger, Denis; Hu, Dale J.; Pau, Chou-Pong; Dobbs, Trudy; Respess, Richard; Coulibaly, Doulourou; Coulibaly, Issa-Malik; Wiktor, Stefan Z.; Greenberg, Alan E.; Rayfield, Mark

Collapse Box


Summary: Limited data exist on the distribution of HIV-1 subtypes in Cote d'Ivoire. The aim of this study is to describe the distribution of genetic subtypes of HIV-1 strains in six regions of Cote d'Ivoire. In 1997, we consecutively collected blood from 172 HIV-1-infected patients from six regional tuberculosis treatment centers. Peripheral blood mononuclear cells (PBMCs) from these people were analyzed by a restriction fragment-length polymorphism (RFLP) assay that involves a sequential endonuclease digestion of a 297-base pair polymerase chain reaction (PCR) fragment; plasma samples were tested by a V3-loop peptide enzyme immunoassay (PEIA). DNA sequencing of the protease or env genes was performed on all samples discordant in the two assays as well as a random sample of the concordant subtyped samples. Of 172 specimens, 3 were PCR-negative, and 169 were putatively classified as subtype A by RFLP. The 3 PCR-negative samples were unequivocally subtyped A by PEIA. Of the 169 RFLP subtype A samples, 159 (94%) were subtyped A by PEIA. Of the 10 discordant samples, PEIA testing classified 3 as subtype C, 2 as D, and 5 as F. Sequencing of the env gene classified these samples as 1 subtype A, 4 Ds, and 5 Gs. Thus, 163 (95%) of the specimens were subtype A, 3 subtype D, 4 subtype G, 1 A/D, and 1 A/G (IbNG) circulating recombinant forms (CRF). In conclusion, most HIV-1- infected tuberculosis patients throughout the interior of Cote d'Ivoire are infected with HIV-1subtype A, which are very likely the A/G (IbNG) CRF. The uniform distribution of this subtype makes Cote d'Ivoire a potential site for vaccine trials.

(C) 2000 Lippincott Williams & Wilkins, Inc.


Article Tools


Article Level Metrics

Search for Similar Articles
You may search for similar articles that contain these same keywords or you may modify the keyword list to augment your search.